PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs
By Holly Campbell | March 3, 2020
Yesterday, PhRMA submitted comments on the Department of Health & Human Services’ (HHS) 2021 Notice of Benefit and Payment Parameters proposed rule. The proposed rule would hurt patients’ ability...
Read More
New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers
By Lauren Neves | September 19, 2018
A new whitepaper authored by Bruce Pyenson, F.S.A., M.A.A.A. and colleagues from Milliman explains why Institute for Clinical and Economic Review (ICER) cost-effective analyses (CEAs) will not be...
Read More
Copay coupons can help ease patients’ out-of-pocket costs
By Holly Campbell | February 16, 2018
Each year, middlemen, like pharmacy benefit managers (PBMs) and insurers, shift more of the costs of health care to patients. Ensuring patients have affordable access to their medicines is the top...
Read More
ICYMI: New report outlines steps for greater transparency in health care
By Katie Koziara | August 4, 2017
Last week, The Network for Excellence in Health Innovation (NEHI) released a new report that outlines steps for greater transparency in health care. The report states that helping consumers make...
Read More
Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.
By Robert Zirkelbach | September 9, 2016
Despite recent headlines, U.S. spending on prescription medicines continues to decline. In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9...
Read More
What’s driving insurance premium increases? Hint: It’s not prescription drugs
By Allyson Funk | August 2, 2016
A new analysis from Avalere Health looks at 2017 proposed health insurance premium increases. As in 2016, insurers’ own data point to outpatient spending as the largest expected driver of premium...
Read More
ICYMI: More attention to adequacy of health insurance coverage
By Allyson Funk | July 8, 2016
On AccessBetterCoverage.org, we’ve been highlighting the growing challenges of insurance benefit design and the impact of high deductibles and out-of-pocket costs on patients. Last week in The...
Read More
Burden on patients: Insurance benefit design’s impact on patient access to medicines
By Allyson Funk | June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...
Read More
Burden on patients: Access to medicines in health insurance exchange plans
By Allyson Funk | June 23, 2016
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...
Read More
Empowering consumers and improving access to out-of-pocket cost information
By Allyson Funk | June 16, 2016
A well-informed consumer is an engaged and empowered patient. One policy solution for delivering innovative treatments to patients is to engage and empower consumers by making more information...
Read More
Medicare Monday (100)
340B Spotlight (45)
Cost & Consequence (0)
